Invasive management could offer better outcome for elderly people with coronary artery disease

September 20, 2001

N.B. please note that if you are outside North America the embargo for Lancet press material is 0001 hours UK time Friday 21 September.

Elderly people with coronary artery disease could have a better prognosis and quality of life if they are given invasive rather than medical treatment, conclude authors of a fast-track study in this week's issue of THE LANCET.

Coronary artery disease (CAD) is the most common cause of illness and death among people aged 75 years or older. Although the size of this age-group is increasing, death rates remain high, and previous research has generally focused on younger populations. Matthias Pfisterer and colleagues from University Hospital, Basel, Switzerland, did a prospective randomised trial to compare the effects of invasive and medical approaches on the outcome and quality of life of elderly patients with CAD.

305 patients aged 75 years or older who had chronic angina (despite having been given standard medication) were studied. They were randomly assigned either coronary angiography and revascularisation (restoration of coronary blood flow using balloon angioplasty and stenting or coronary artery bypass-graft-surgery) or optimised medical therapy. The primary endpoint was quality of life after 6 months (assessed by questionnaire), and the presence of major adverse cardiac events (death, non-fatal heart attack, or hospital admission for acute coronary syndrome).

After 6 months, angina severity decreased and measures of quality of life increased in both treatment groups; however, these improvements were substantially greater in patients who underwent revascularisation. Major adverse cardiac events occurred in 72 (49%) of patients in the medical group and 29 (19%) in the invasive group.

Matthias Pfisterer comments: "Patients aged 75 years or older with angina despite standard drug therapy benefit more from vascularisation than from optimised medical therapy in terms of symptom relief and quality of life. Therefore, these patients should be offered invasive assessment despite their high risk-profile followed by revascularisation if feasible."

In an accompanying Commentary (p 945), Wilbert Aronow from Westchester Medical Center and New York Medical College, USA, observes that only 6.7% of 720 000 patients involved in 593 published trials of patients with acute coronary syndromes have been 75 years or older. He confirms Pfisterer and colleagues' conclusion that elderly patients should be offered invasive evaluation and coronary revascularisation procedures (as clinically indicated), despite their high-risk profile.
-end-
Contact: Professor Matthias E Pfisterer, Division of Cardiology, Department of Internal Medicine, University Hospital, CH-4031 Basel, Switzerland; T) 41-61-265-5214; F) 41-61-265-4598; E) pfisterer@email.ch

Dr Wilbert S Aronow, Department of Medicine, Divisions of Cardiology and Geriatrics, Westchester Medical Center and New York Medical College, Valhalla, NY 10595, USA; E) WSAronow@aol.com

Lancet

Related Coronary Artery Disease Articles from Brightsurf:

Researchers use multi-ancestry comparison to refine risk factors for coronary artery disease
An international group led by researchers from the RIKEN Center for Integrative Medical Sciences have used a combination of genome-wide association analysis--or GWAS--and a trans-ancestry comparison of different GWAS studies, to come up with a more accurate predictor of coronary artery disease based on genetic factors.

Oral radiography can reveal chronic coronary artery disease
A study found a link between carotid artery calcification observable in radiographs and coronary artery disease as well as several oral infections.

A new strategy to counter insulin damage in coronary artery disease
By studying blood vessel tissue from 674 patients, a research team has discovered how insulin contributes to the dysfunction of blood vessels in atherosclerosis, one of the most common chronic health conditions worldwide.

3D fusion imaging improves coronary artery disease diagnosis
A new technique that combines CT and MRI can bolster coronary artery disease diagnosis and help to define appropriate treatment for patients suffering from the disease, according to a new study.

Associations between vaspin levels and coronary artery disease
In a new publication from Cardiovascular Innovations and Applications; DOI https://doi.org/10.15212/CVIA.2019.0565, Lutfu Askin, Okan Tanriverdi, Hakan Tibilli and Serdar Turkmen from the Department of Cardiology, Adiyaman Education and Research Hospital, Adiyaman, Turkey consider associations between vaspin levels and coronary artery disease.

Waist size, not body mass index, may be more predictive of coronary artery disease
For years, women have been told that weight gain could lead to heart disease.

Women with coronary artery wall thickness at risk for heart disease
The thickness of the coronary artery wall as measured by MRI is an independent marker for heart disease in women, according to a new study.

SPIE journal reports advances in use of 3D models in assessing coronary artery disease
In an article published in SPIE's Journal of Medical Imaging (JMI), researchers announce critical advances in the use of 3D-printed coronary phantoms with diagnostic software, further developing a non-invasive diagnostic method for Coronary Artery Disease (CAD) risk assessment.

E-cigarettes linked to heart attacks, coronary artery disease and depression
Concerns about the addictive nature of e-cigarettes -- now used by an estimated 1 out of 20 Americans -- may only be part of the evolving public health story surrounding their use, according to data being presented at the American College of Cardiology's 68th Annual Scientific Session.

Is guideline-recommended therapy for coronary artery disease more likely in Medicare Advantage?
Medicare Advantage is Medicare's managed-care alternative to traditional fee-for-service Medicare.

Read More: Coronary Artery Disease News and Coronary Artery Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.